Partner Institutions


KULKatholieke Universiteit Leuven (K.U.Leuven)
The Katholieke Universiteit Leuven, founded in 1425, is a Flemish University of Catholic signature with an international orientation. It has the legal status of a private institution.
As a university, K.U.Leuven is an academic institution at which both groundbreaking research and knowledge transfer are essential and complementary.
HeMiBio Principal Investigators: Prof. Dr. Catherine Verfaillie (Scientific Coordinator) and Dr. Aernout Luttun

VUBVrije Unversiteit Brussel (VUB)
The Vrije Universiteit Brussel is a dynamic and modern university with two parkland campuses in the Brussels Capital Region. High quality education and research are central issues. Our research teams are internationally recognised in many disciplins of fundamental and applied research.
HeMiBio Principal Investigators: Dr. Leo van Grunsven and Prof. Dr. Vera Rogiers

IMECInteruniversitair Micro-Electronica Centrum VZW (IMEC)
Imec performs world-leading research in nanoelectronics. We leverage our scientific knowledge with the innovative power of our global partnerships in ICT, healthcare and energy. We deliver industry-relevant technology solutions. In a unique high-tech environment, our international top-talent is committed to providing the building blocks for a better life in a sustainable environment.
HeMiBio Principal Investigator: Dr. Jan Vanfleteren




FraunhoferFraunhofer Gesellschaft zur Foerderung der angewandten Forschung e.V
Fraunhofer is Europe’s largest application-oriented research organization. Research efforts are geared entirely to people’s needs: health, security, communication, energy and the environment. As a result, the work undertaken by Fraunhofer researchers and developers has a significant impact on people’s lives.
HeMiBio Principal Investigators: Dr. Magnus Jäger (IBMT) and Dr. Thomas Löher (IZM)

medicyteMedicyte GmbH (Medicyte)
Medicyte is focused on technologies for the production of scalable quantities of primary cells at a consistent high quality for research, industrial and therapeutic applications. Medicyte's vision is to establish unique and proprietary technologies as gold standards and preferred source for human primary cells and human cell-based applications.
HeMiBio Principal Investigator: Dr. Joris Braspenning

MHHMedizinische Hochschule Hannover (MHH) - HeMiBio Partner until June 2012
The Hannover Medical School, founded in 1965, is one of the world's leading university medical centres. MHH's research and patient care set national and international standards. MHH is also part of an excellent regional medical network. The outstanding success in interdisciplinary collaboration both within the MHH and with extramural scientific institutions is reflected in the fact that the MHH is the German medical university with the greatest volume of grant funding.
HeMiBio Principal Investigator: Dr. Toni Cathomen


UKF LogoUniversitätsklinikum Freiburg (UKL-FR) - HeMiBio Partner since July 2012
The University Medical Center Freiburg (UKL-FR) is one of the largest medical centers in Europe, with representations of all medical specialties. The University Medical Center is part of the Albert Ludwigs University Freiburg, which can be traced back to 1457, thus making the medical faculty one of the oldest and most distinguished faculties in Germany.
HeMiBio Principal Investigator: Dr. Toni Cathomen



HUJIThe Hebrew University of Jerusalem (HUJI)
HU researchers figure at the forefront of international science - from biotechnology and computer science to astrophysics and cancer research, from microbiology to solar energy and genetic engineering, as well as the humanities, including Jewish studies, social sciences and law.
HeMiBio Principal Investigator: Dr. Yaakov Nahmias



Universitetet i Oslo (UIO)
The University of Oslo is Norway’s largest and oldest institution of higher education.
HeMiBio Principal Investigator: Dr. Philippe Collas



UITUniversitetet i Tromsø (UIT)
The University of Tromsø is the northernmost university of the world. UIT is an international institution working for high quality in research and in scientific and artistic development.
HeMibio Principal Investigator: Prof. Dr. Bård Smedsrød





IDIBAPSConsorci Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS)
The fundamental mission of IDIBAPS is to combine clinical research of proven quality with high-level basic research. IDIBAPS scientific staff come from its constituent institutions: Hospital Clínic de Barcelona, the University of Barcelona School of Medicine, the CSIC’s Barcelona Biomedical Research Institute and the staff recruited by the Fundació Clínic.
HeMiBio Principal Investigator: Dr. Pau Sancho-Bru



CSEMCentre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement (CSEM)
CSEM founded in 1984, is a private applied research and development center specializing in micro- and nanotechnology, system engineering microelectronics and communications technologies.CSEM's mission is to enhance the competitiveness of industry, particularly Swiss industry, by developing applied technology platforms in micro- and nanotechnologies and ICT and transferring them to the industrial sector.
HeMiBio Prinicipal Investigator: Dr. Silvia Generelli



ITInserm Transfert SA, Paris
Founded in 2001, Inserm-Transfert SA is the private subsidiary of the French Institute for Health and Medical Research (INSERM), dedicated to intellectual property management, technology transfer, industrial partnerships and the management of European and International collaborative research projects.
HeMiBio Project Manager: Dr. Christiane Dascher-Nadel